LUCENTIS 10mg/ml Price

Overview

Welcome to Dwaey, specifically on LUCENTIS 10mg/ml Injection/Solution for page.
This medicine contains an important and useful components, as it consists of Ranibizumab.
LUCENTIS 10mg/ml is available in the market in concentration 10mg/ml and in the form of Injection/Solution for.

NOVARTIS PHARMA AG is the producer of LUCENTIS 10mg/ml and it is imported from SWITZERLAND, The most popular alternatives of LUCENTIS 10mg/ml are listed downward .

Mode Of Action

Humanized monoclonal antibody to VEGF-A, inhibits VEGF-A-induced ocular neovascularization.

Indication

• Wet ARMD
• Central retinal vein occlusion
• Diabetic macular edema

Precaution

Patient w/ risk factors for retinal pigment epithelial tears, history of stroke or transient ischaemic attack, uncontrolled HTN, previous intravitreal inj, active systemic infections, proliferative diabetic retinopathy, diabetic macular oedema due to type 1 DM. Discontinue treatment if rhegmatogenous retinal detachment or stage 3 or 4 macular hole develops. Diabetic patients w/ glycosylated Hb over 12%. Lactation: Unknown if distributed in milk; use caution

Side Effects

• >10% Conjunctival hemorrhage (43-77%)
• Eye pain (17-37%)
• Vitreous floaters (3-32%)
• Incr IOP (8-24%)
• Vitreous detachment (7-22%)
• Eye irritation (4-19%)
• Intraocular inflammation (5-18%)
• Headache (2-15%)
• Upper resp tract infection (2-15%)
• Retinal disorder (13%)
• Blepharitis (3-13%)
• Retinal degeneration (1-11%) 1-10% Conjunctival hyperemia (9%)
• Posterior capsule opacification (8%)
• Injection site hemorrhage (5%)
• Vitreous hemorrhage (4%)

Contra indication

Active or suspected ocular or periocular infection, active severe intraocular inflammation, signs of irreversible ischaemic visual function loss in patients w/ retinal vein occlusion.

Pregnancy and lactation

Pregnancy category: C

Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks